Tau protein binds to pericentromeric DNA: a putative role for nuclear tau in nucleolar organization

Cited by (166)

Items 101–166 of 166

1. Emerging Connections Between Tau and Nucleic Acids
   Marie‐Christine Galas, Eliette Bonnefoy, Luc Buée, Bruno Lefebvre · 2019 · Advances in experimental medicine and biology
2. Activation of Neuronal Defense Mechanisms in Response to Pathogenic Factors Triggering Induction of Amyloidosis in Alzheimer's Disease
   Alexander V. Maltsev, Rasa Santockyte, Simon M. Bystryak, Oxana V. Galzitskaya · 2014 · Journal of Alzheimer s Disease
3. Pathological-Like Assembly of tau Induced by a Paired Helical Filament Core Expressed at the Plasma Membrane
   Victoria Campos‐Peña, José Tapia-Ramı́rez, Carmen Sánchez‐Torres, Marco Antonio Meraz‐Ríos · 2009 · Journal of Alzheimer s Disease
4. Anomalous Protein–DNA Interactions Behind Neurological Disorders
   Sergio Camero, María José Benítez, Juan S. Jiménez · 2013 · Advances in protein chemistry and structural biology
5. The IDIP framework for assessing protein function and its application to the prion protein
   Gerold Schmitt‐Ulms, Mohadeseh Mehrabian, Declan Williams, Sepehr Ehsani · 2021 · Biological reviews/Biological reviews of the Cambridge Philosophical Society
6. Genotype-Specific Differences between Mouse CNS Stem Cell Lines Expressing Frontotemporal Dementia Mutant or Wild Type Human Tau
   Miranda E. Orr, Rose Pitstick, Brenda Canine, Karen H. Ashe, George A. Carlson · 2012 · PLoS ONE
7. Transcriptional programs mediating neuronal toxicity and altered glial–neuronal signaling in a Drosophila knock-in tauopathy model
   Hassan Bukhari, Vanitha Nithianandam, Rachel A. Battaglia, Anthony Cicalo, Souvarish Sarkar, Aram Comjean, Yanhui Hu, Matthew Joseph Leventhal, Xianjun Dong, Mel Β. Feany · 2024 · Genome Research
8. Looking at Alzheimer’s Disease Pathogenesis from the Nuclear Side
   Laura D’Andrea, Ramona Stringhi, Mónica Di Luca, Elena E. Marcello · 2021 · Biomolecules
9. Oligomeropathies, inflammation and prion protein binding
   Gianluigi Forloni, Pietro La Vitola, Claudia Balducci · 2022 · Frontiers in Neuroscience
10. To aggregate or not to aggregate – Is it a matter of the ribosome?
    Sebastian Iben · 2023 · BioEssays
11. Intensive protein synthesis in neurons and phosphorylation of beta-amyloid precursor protein and tau-protein are triggering factors of neuronal amyloidosis and Alzheimer's disease
    Alexander V. Maltsev, Nikita V. Dovidchenko, Victor Konstantinovich Uteshev, Viktoriya V. Sokolik, O. M. Shtang, M. A. Yakushin, N. M. Sokolova, Alexey K. Surin, Oxana V. Galzitskaya · 2013 · Biomeditsinskaya Khimiya
12. What Have We Learned from the Tau Hypothesis?
    Ricardo Benjamin Maccioni, Gustavo A. Farias, Leonel E. Rojo, M. Alejandra Sekler, Rodrigo Orlando Kuljiš · 2009 · Springer eBooks
13. EGCG modulates nuclear formaldehyde-induced Tau phosphorylation in Neuronal cells
    Shweta Kishor Sonawane, Anshu Raina, Amitabha Majumdar, Subashchandrabose Chinnathambi · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
14. Trichloroacetic acid treatment as a tricky way for rapid purification of 1N/4R tau protein
    Kazem Asadollahi, Saharnaz Rafiee, Gholam Hossein Riazi, Shahriar Pooyan, Ali Afrasiabi · 2015 · Protein Expression and Purification
15. The role of non-enzymatic glycation on Tau-DNA interactions: Kinetic and mechanistic approaches
    Reza Yekta, Leila Sadeghi, Gholamreza Dehghan · 2022 · International Journal of Biological Macromolecules
16. Cell Cycle Reactivation, at the Start of Neurodegeneration, Induced by Forskolin and Aniline in Differentiated Neuroblastoma Cells
    Valentina Sturiale, Francesca Bruno, Desiree Brancato, Agata Grazia D’Amico, Grazia Maugeri, Velia D’Agata, Salvatore Saccone, Concetta Federico · 2023 · International Journal of Molecular Sciences
17. Chromatin Changes Associated with Neuronal Maintenance and Their Pharmacological Application
    Jang Ho Lee, Jeong‐Hoon Kim, Sunhong Kim, Kyoung Sang Cho, Sung Bae Lee · 2017 · Current Neuropharmacology
18. Ultrasmall Gold Nanoparticles as Clients of Biomolecular Condensates
    Giovanna Viola, Fulvio Floriani, Carlo Giorgio Barracchia, Francesca Munari, Mariapina D’Onofrio, Michael Assfalg · 2023 · Chemistry - A European Journal
19. Tau mediates the reshaping of the transcriptional landscape toward intermediate Alzheimer’s disease stages
    Giacomo Siano, Martina Varisco, Marco Terrigno, Congwei Wang, Arianna Scarlatti, Vincenzo Iannone, Marco Groth, Marie‐Christine Galas, Jeroen J.M. Hoozemans, Alessandro Cellerino et al. · 2025 · Frontiers in Cell and Developmental Biology
20. Controlled Tau Cleavage in Cells Reveals Abnormal Localizations of Tau Fragments
    Anne Fourest‐Lieuvin, Angélique Vinit, Béatrice Blot, Anthime Perrot, Éric Denarier, Frédéric Saudou, Isabelle Arnal · 2022 · Neuroscience
21. Loss of AT8 Nuclear Tau as a Marker of Neuronal Ageing and Alzheimer’s Disease Progression
    Francesca Bruno, Laura Gil, Valentina Sturiale, Carmen Guerrero, Ana Belén Rebolledo Poves, Desiree Brancato, Javier Morales, Salvatore Saccone, Concetta Federico · 2025 · Biomedicines
22. PATHOPHYSIOLOGY OF ALZHEIMER'S DISEASE: EXPERIMENTAL AND GENETIC FINDINGS
    Esen Saka · 2010 · The Turkish Journal of Geriatrics
23. Irreversible modifications of chromatin and the nuclear lamina: A review inside the nuclear origin of Alzheimer’s disease
    Laura Gil, Gabriela Capdeville, Ildefonso Rodríguez‐Leyva, Sandra Aurora Niño, María Esther Jiménez-Capdeville · 2021 · Revista de Fomento Social
24. Tau condensation on DNA mediates microtubule attachment suggesting a mitotic role for centromere-localized tau
    Celine Park, Jaehun Jung, Yuri Hong, Haeun Yoo, Keunsang Yang, Jaehyeon Shin, Minsik Kim, Chan Seok Lim, Ayoung Jeong, Seokyun Hong et al. · 2026 · Nature Communications
25. Double vision: Pigment genes do more than just color
    Ambegaokar, Surendra S., Jackson, George · 2011 · Fly
26. Effects of Formaldehyde on Protein (Tau) Aggregation and Cytotoxicity
    Rongqiao He · 2017 · Springer eBooks
27. Nuclear Tau as an Early Molecular Marker of Alzheimer’s Disease
    Francesca Bruno, Valentina Sturiale, Desiree Brancato, Laura Gil, Isabel M. Olazabal, Fernando Pinedo, Ana Belén Rebolledo Poves, Salvatore Saccone, Concetta Federico · 2023 · International Electronic Conference on Biomedicines (IECBM)
28. Tau alters global gene expression affecting chromatin in the early stages of Alzheimer’s disease
    Giacomo Siano, Martina Varisco, Marco Terrigno, C. Wang, Marco Groth, Marie‐Christine Galas, Jeroen J.M. Hoozemans, Alessandro Cellerino, Antonino Cattaneo, Cristina Di Primio · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
29. Delaying Brain Aging or Decreasing Tau Levels as Strategies to Prevent Alzheimer’s Disease: In Memoriam of Mark A. Smith
    Jesús Ávila · 2024 · Journal of Alzheimer s Disease
30. Tau modulates nuclear integrity, chromatin, and cholesterol synthesis genes via the nuclear envelope
    Lisa Diez, Renata Ponce-Lina, Cagla Kilic, Rithika Sankar, Frieda Balduin, Cong Wang, Pia Grundschöttel, Koki Sakurai, Bilge Askin, Chiara Bordier et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
31. Human nuclear tau and aging
    Concetta Federico, Francesca Bruno, Valentina Sturiale, Agata Grazia D’Amico, Grazia Maugeri, Velia D’Agata, Laura Gil, Salvatore Saccone · 2021 · Elsevier eBooks
32. Tau Pathology
    Nicolas Sergeant, Luc Buée · 2010 · Advances in neurobiology
33. Investigating Tau pathology in an in vitro model for Alzheimer’s disease
    Yigael S. L. Powrie · 2016 · SUNScholar (Stellenbosch University)
34. Nuclear Tau modulates VGluT1 expression: a new function for Tau
    Giacomo Siano, Martina Varisco, Maria Claudia Caiazza, Valentina Quercioli, Marco Mainardi, Chiara Ippolito, Antonino Cattaneo, Cristina Di Primio · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
35. Aging device: tau protein transposes the telomere fragment into promoter/enhancer to promote gene copy number decrement regulation
    Wenzhong Liu, Li hualan · 2024 · ChemRxiv
36. Aging device: tau protein transposes the telomerase fragment into promoter/enhancer to promote gene copy number decrement regulation
    Wenzhong Liu, Li hualan · 2024 · ChemRxiv
37. Mutant MAPT Induces rDNA Transcriptional Hyperactivation and Nucleolar Stress in Cellular Models
    Zaid Muhammad, Yan Gu, Suleiman Hamidu Kwairanga, Laura J. Bailey, Amna Khan, Mohammad Nasser, Dana Aljarrah, Charles Arber, Selina Wray, Louise C. Serpell et al. · 2025 · Research Square
38. Mouse and stem cell models of frontotemporal dementia
    Miranda E. Orr · 2012 · Montana State University ScholarWorks (Montana State University)
39. Functional implications of tau-fyn interactions in Alzheimer's disease
    Hay Wun Dawn Lau · 2015
40. Neurochemical Aspects of β-Amyloid Cascade Hypothesis for Alzheimer’s Disease
    A. A. Farooqui · 2017 · Elsevier eBooks
41. Investigating the contribution of astrocytes and neuroinflammation to pathological tau changes in Alzheimer's disease
    Emma Claire Phillips · 2017 · Research Portal (King's College London)
42. Emerging role of RNA-binding proteins in sporadic and rapid progressive Alzheimer’s disease
    Neelam Younas · 2020
43. THE ROLE OF MICROTUBULE-ASSOCIATED PROTEIN TAU IN NEURONAL EXCITABILITY AND EPILEPTOGENESIS
    Ryan Cloyd · 2021 · UKnowledge (University of Kentucky)
44. Quantification and Analysis of Tau Protein Effects on Microtubule Dynamics in Mammalian (LLC-PK1) Cells
    Alexandra Doersch · 2020 · University of Minnesota Digital Conservancy (University of Minnesota)
45. Tau and Tauopathies
    Robert Mathew, Guduru Vijay Srinivas, Pavagada Sivasankara Mathuranath · 2010 · Advances in neurobiology
46. Extracellular Tau Oligomers Induce Disruption of Endogenous Tau Distribution, Invasion of Tau into the Somatodendritic Compartment and Axonal Transport Dysfunction
    Eric C Swanson · 2017
47. Intensive protein synthesis in neurons and phosphorylation of beta-amyloid precursor protein and tau-protein are triggering factors of neuronal amyloidosis and Alzheimer’s disease
    Alexander V. Maltsev, Nikita V. Dovidchenko, Victor Konstantinovich Uteshev, Viktoriya V. Sokolik, O. M. Shtang, M. A. Yakushin, N. M. Sokolova, Alexey K. Surin, Oxana V. Galzitskaya · 2013 · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry
48. Association of Conformationally Altered Tau with α-1-antichymotrypsin in the Nuclei of Neurons in the Alzheimer's Disease Brain
    Perla H. Horta‐López, Jan Říčný, Benjamí­n Florán, Francisco García‐Sierra · 2023 · Journal of Experimental Neurology
49. Multifunctional Protein Tau Aggregation and Cytotoxicity
    Xiaping He, Yang Lü, Rong-Qiao He · 2025 · Springer eBooks
50. Comparisons between young, aged, and Alzheimer’s brains reveal specific expression patterns for a subset of transposons and satellite repeats
    Elif Turan, Büşranur Çeltik, Gökçe Dağlar, İlayda Kaya, Mert Tüfekçİ, Cihangir Yandım · 2025 · Journal of Biosciences
51. Impact of Tau overexpression on DNA replication dynamics in centromeres of human neural progenitor cells
    Elisa Balzano, Shyam Twayana, Settapong T Kosiyatrakul, Glennis A. Logsdon, Bhushan L. Thakur, Evan E. Eichler, Bettina Bohl, Philipp Koch, Simone Sidoli, Anupama Kumari et al. · 2026 · iScience
52. Modélisation pathologique des maladies monogéniques par l'utilisation des cellules souches embryonnaires humaines : preuve de concept appliquée à la dystrophie myotonique de type 1
    Jérôme Alexandre Denis · 2010 · theses.fr (ABES)
53. Étude de la toxicité neuronale induite par la protéine Tau dans la maladie d’Alzheimer, sur un modèle Invertébré : Drosophila melanogaster
    Yasmina Talmat-Amar · 2012
54. Tau nucléaire : un acteur clé dans le stress neuronal
    Audrey Sultan · 2010 · theses.fr (ABES)
55. Agrégation de tau et a-synucleine dans les maladies neurodégénératives : mise au point de nouveaux modèles in vitro et in vivo
    Andrei Yu. Roman · 2018 · theses.fr (ABES)
56. Les nanotubes comme nouvelle voie de transfert et de propagation de la protéine Tau pathologique
    Meryem Tardivel · 2017 · theses.fr (ABES)
57. Rôle de la dérégulation neuronale de la protéine kinase activée par l’AMP (AMPK) dans la pathologie tau, l’intégrité des synapses et le métabolisme énergétique : relevance pour la maladie d’Alzheimer
    Manon Domise · 2018 · theses.fr (ABES)
58. Biological Activities of Nucleolin Aptamer AS1411 Grafted to Gold Nanospheres : From Synthesis to Mechanistic Studies
    Samaneh Kabirian Dehkordi · 2019
59. Neurotoxicité précoce et mécanismes de neuroprotection dans des modèles poisson‐zèbre de tauopathies
    Clément Barbereau · 2020 · theses.fr (ABES)
60. Identification et caractérisation fonctionnelle de nouveaux sites de clivage de la protéine Tau
    Maxime J. Derisbourg · 2015 · theses.fr (ABES)
61. Étude biophysique de l'interaction protéine tau - zinc
    Romain La Rocca · 2020
62. Caractérisation d'anticorps à domaine unique dirigés contre la protéine Tau
    Clément Danis · 2018 · theses.fr (ABES)
63. Interaction entre la protéine Tau et la protéine p54nrb : effet sur la maturation des miARN au sein des paraspeckles
    Marine Denéchaud · 2022 · theses.fr (ABES)
64. Replicable generation and stable maintenance of rhesus macaque iPSCs for in vitro modeling of genetic frontotemporal dementia
    Julia C. Colwell, John P. Maufort, Kathryn M Williams, Allison T. Makulec, Melissa V. Fiorentino, Jeanette M. Metzger, Heather A. Simmons, Puja Basu, Kerri B. Malicki, Celeste M M. Karch et al. · 2026 · Frontiers in Cell and Developmental Biology
65. The truncated Tau fragment 315–441 produced by Caspase-2 translocates to the nucleus and alters the proteome of neuroblastoma cells
    Yadira Ivonne López-Aviña, Emmanuel Ríos‐Castro, Fanny Rodríguez‐Cruz, Graciela Mendoza-Franco, Bulmaro Cisneros Vega, Antony A. Boucard, Juan Pedro Luna‐Arias, Gustavo Basurto‐Islas, Francisco García‐Sierra · 2026 · European Journal of Cell Biology
66. Targeting tau acetylation in Alzheimer's disease: Molecular mechanisms, pathological consequences, and therapeutic opportunities of dietary phytochemicals
    Basavaraju KC, Poornima Priyadarshini C. G. · 2026 · Biochemical and Biophysical Research Communications